Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier Program
Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier Program Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier Program PR Newswire SAN DIEGO, Aug. 13, 2026 Conference Call Today at 4:30 p.m. ETSAN DIEGO, Aug. 13, 2026 /PRNewswire/ -- Aethlon Medical...
PR Newswire
Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026
Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026 Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026 PR Newswire SAN DIEGO, Aug. 5, 2026 SAN DIEGO, Aug. 5, 2026 /PRNewswire/ -- Aethlon Medical...
PR Newswire
Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier
Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier PR Newswire SAN DIEGO, July...
PR Newswire
Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules
Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules PR Newswire SAN DIEGO, July 6, 2026 SAN DIEGO, July 6, 2026 /PRNewswire...
PR Newswire
Aethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier
Aethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier Aethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier PR Newswire SAN DIEGO, June 26...
PR Newswire
Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update
Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update PR Newswire SAN DIEGO, June 10, 2026 Australian oncology study advances into Cohort 3 as enrollment...
PR Newswire
The Next Meme Stock Wave?
A fresh wave of speculative activity swept through the small-cap market this week as traders piled into a combination of AI-linked companies, China-based growth stories, and emerging defense contractors. $BLIS, $GMM, $PAVS, $AEMD, $PAYO, $AZI, $CGTL, $CCSC, $ELPW, $JZXN, $MTEN
24-7 Market News
Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026
Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026 Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026 PR Newswire SAN DIEGO, June 2, 2026 SAN DIEGO, June 2, 2026 /PRNewswire/ --Aethlon Medical...
PR Newswire
Aethlon Medical Monitoring Current Ebola Outbreak and Reaffirms Outbreak/Pandemic Preparedness
Aethlon Medical Monitoring Current Ebola Outbreak and Reaffirms Outbreak/Pandemic Preparedness Aethlon Medical Monitoring Current Ebola Outbreak and Reaffirms Outbreak/Pandemic Preparedness PR Newswire SAN DIEGO, May 21, 2026 SAN DIEGO, May 21, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ...
PR Newswire
Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review
Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive...
PR Newswire